WHO recommends Gilead's twice-yearly injection for HIV prevention – Reuters
- WHO recommends Gilead’s twice-yearly injection for HIV prevention Reuters
- Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis World Health Organization (WHO)
- WHO Endorses Gilead Sciences’ Biannual Drug Yeztugo for HIV Prevention geneonline.com
- Momentum Builds For Long-Acting HIV Solutions POZ – Health, Life and HIV
- WHO urges rollout of first long-acting HIV prevention jab UN News